Loomis Sayles & CO L P Royalty Pharma PLC Transaction History

Loomis Sayles & CO L P

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 13, 2024	BUY	$26.21 - $29.22 $8,544 - $9,525	326 Added 108.31%	627 $18,000
Q2 2023 Aug 11, 2023	SELL	$29.6 - $36.56 $1,006 - $1,243	-34 Reduced 10.15%	301 $9,000
Q1 2023 May 11, 2023	BUY	$32.77 - $39.4 $10,977 - $13,199	335 New	335 $12,000
Q3 2022 Nov 14, 2022	SELL	$39.88 - $44.65 $1,316 - $1,473	-33 Reduced 46.48%	38 $2,000
Q1 2022 May 13, 2022	BUY	$37.46 - $42.44 $2,659 - $3,013	71 New	71 $3,000
Q4 2021 Feb 14, 2022	SELL	$35.17 - $42.48 $8,018 - $9,685	-228 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$36.14 - $42.24 $8,239 - $9,630	228 New	228 $8,000

413

283M

578K

47.5K

Ticker RPRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 437,139,008
Market Cap $10.6B
Description
Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...

Get notified when there are updates to the investment portfolio of Loomis Sayles & CO L P, based on Form 13F filings with the SEC.

Stay updated on Loomis Sayles & CO L P with notifications on news.